The finalist teams were announced in the Qualcomm Tricorder XPRIZE. The submissions of the 10 finalists were the best amongst 21 submitted. Judging criteria included health assessment, user experience and safety. The finalists will have their submissions subjected to consumer testing and evaluations of diagnostic experience. Successful submissions are supposed to diagnose five vital signs, and at least 13 health conditions. That’s certainly a fair distance from what the Star Trek Medical Tricorder can do, but that one is fictional.
The 10 finalist teams represent six countries:
- Aezon (Rockville, Maryland), led by Tatiana Rypinski, a team of student engineers from Johns Hopkins University partnering with the Center for Bioengineering Innovation & Design.
- CloudDX (Mississauga, Canada), a team from medical devices manufacturer Biosign and led by company chief medical officer, Dr. Sonny Kohli.
- Danvantri (Chennai, India), a team from technology manufacturer American Megatrends India and led by company Director and CEO, Sridharan Mani.
- DMI (Cambridge, Massachusetts), a team led by Dr. Eugene Y. Chan of the DNA Medicine Institute partnering with NASA, the National Institutes of Health and the Bill and Melinda Gates Foundation.
- Dynamical Biomarkers Group (Zhongli City, Taiwan), a team of physicians, scientists and engineers led by Harvard Medical School professor Chung-Kang Peng.
- Final Frontier Medical Devices (Paoli, Pennsylvania), a team led by the founders of Basil Leaf Technologies—brothers Dr. Basil Harris, an emergency room physician, and George Harris, a network engineer.
- MESI Simplifying diagnostics (Ljubljana, Slovenia), a team from diagnostic medical device manufacturer MESI and led by company CEO, Jakob Susteric.
- SCANADU (Moffett Field, California), a team from Silicon Valley-based start-up SCANADU led by technology entrepreneur and company co-founder and CEO, Walter De Brouwer.
- SCANurse (London, England), a team from diagnostic medical manufacturer SCANurse and led by biomedical engineer and company founder, Anil Vaidya.
- zensor (Belfast, Ireland), a team from clinical sensor and electrode company Intelesens and led by chief technology officer, Prof. Jim McLaughlin.
Final round testing will take place in the second half of 2015, with the expected awarding of the prize to a qualifying team in 2016.